Success Story: NIW Approval for a Taiwanese Molecular Biology Researcher Advancing Alzheimer’s Disease Treatment
Client’s Testimonial:
"I am incredibly grateful to the team at Wegreen for their exceptional support throughout my NIW application. Their team is highly professional and made a complex process feel manageable. I was particularly impressed by how quickly and clearly they responded to all of my inquiries, ensuring I felt confident at every step. I highly recommend their services to any researcher seeking EB-2 NIW approval."
On April 11th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Ph.D. Student in the Field of Molecular Biology (Approval Notice).
General Field: Molecular Biology
Position at the Time of Case Filing: Ph.D. Student
Country of Origin: Taiwan
State of Residence at the Time of Filing: Texas
Approval Notice Date: April 11th, 2026
Processing Time: 9 months, 30 days (Premium Processing Requested)
Case Summary:
“Her work provides critical insight into how certain signaling processes preserve cellular health and how their disruption leads to disease. Consequently, her contribution to scientific understanding tackles an urgent biomedical need to uncover new ways to combat age-related disorders and prevent early cellular breakdown.”
That assessment from a recommendation letter captured the heart of this NIW case. A Ph.D. student from Taiwan earned NIW approval on April 11, 2026, after 9 months and 30 days with Premium Processing. Her case focused on a proposed endeavor in molecular biology aimed at developing novel treatments for Alzheimer’s disease and improving patient outcomes while reducing the broader burden of neurodegenerative disorders.
At North America Immigration Law Group (Chen Immigration Law Associates), we framed her work around a pressing national need. The petition explained that her research applies advanced biomedical methodologies to study disease susceptibility, protective pathways in the brain, and neuroprotective treatment strategies. Her work drew on transgenic mouse models, transcriptomic profiling, advanced imaging techniques, and other experimental approaches to better understand why Alzheimer’s disease develops and how it may be treated more effectively.
To establish that she was well-positioned to advance the endeavor, we documented a record of achievement that was strong for a researcher at her career stage:
- 3 peer-reviewed journal articles
- 4 first-authored conference abstracts
- 92 citations
The petition also showed that other researchers were already relying on her work. Independent scholars used her findings to study complex neurological pathways, neuroinflammatory conditions, and cellular mechanisms in neurodegenerative disease research. That pattern of reliance helped demonstrate that her contributions were not isolated academic observations, but foundational research actively shaping later investigations in the field.
This approval reflects how a strong NIW petition can connect molecular biology research to urgent public health needs in the United States. By showing the significance of her Alzheimer’s disease research, the influence of her prior findings, and the realistic path toward future therapeutic advances, we secured a successful result for a promising researcher in a field that affects millions of families.